Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gibble

Showing results (111-120 of 130) with videos related to

Pageof 13
Sort By:
Neurology|February 1, 1997
HTLV-associated myelopathy in a cohort of HTLV-I and HTLV-II-infected blood donors. The REDS investigatorsE L Murphy, J Fridey, J W Smith, et al.
Neurology|September 10, 2009
Neurologic abnormalities in HTLV-I- and HTLV-II-infected individuals without overt myelopathyH H Biswas, J W Engstrom, Z Kaidarova, et al.
Physical Review Letters|December 27, 2015
Towards a Mg Lattice Clock: Observation of the ^{1}S_{0}-^{3}P_{0} Transition and Determination of the Magic WavelengthA P Kulosa, D Fim, K H Zipfel, et al.
Expert Review of Gastroenterology & Hepatology|March 21, 2024
Histologic assessments in ulcerative colitis: the evidence behind a new endpoint in clinical trialsRish K Pai, Geert D'Haens, Taku Kobayashi, et al.
Digestive Diseases and Sciences|May 3, 2024
Patient and Health Care Professional Perceptions of the Experience and Impact of Symptoms of Moderate-to-Severe Crohn's Disease in US and Europe: Results from the Cross-Sectional CONFIDE StudyStefan Schreiber, Theresa Hunter Gibble, Remo Panaccione, et al.
Crohn'S & Colitis 360|May 14, 2025
US and European Patient and Health Care Professional Perspectives on Fatigue in Ulcerative Colitis and Crohn's Disease: Results From the Communicating Needs and Features of Inflammatory Bowel Disease Experiences SurveyRemo Panaccione, Alison Potts Bleakman, Stefan Schreiber, et al.
Diabetes, Obesity & Metabolism|February 4, 2026
A treat-to-target approach for obesity management: A post hoc analysis of the SURMOUNT-5 trialCarel W le Roux, Luca Busetto, Louis Aronne, et al.
Rheumatology and Therapy|December 19, 2025
Does HLA-B27 Status Influence Ixekizumab Efficacy in Axial Spondyloarthritis? Results From the COAST-V, COAST-W, and COAST-X TrialsJohn D Reveille, Martin Rudwaleit, Proton Rahman, et al.
Physical Review Letters|February 10, 2025
Lattice Light Shift Evaluations in a Dual-Ensemble Yb Optical Lattice ClockTobias Bothwell, Benjamin D Hunt, Jacob L Siegel, et al.
Crohn'S & Colitis 360|February 5, 2024
Association of Bowel Urgency With Quality-of-Life Measures in Patients With Moderately-to-Severely Active Ulcerative Colitis: Results From Phase 3 LUCENT-1 (Induction) and LUCENT-2 (Maintenance) StudiesMillie D Long, Stefan Schreiber, Toshifumi Hibi, et al.
Pageof 13

Showing results (111-120 of 130) with videos related to

Sort By:
Pageof 13
Neurology|February 1, 1997
HTLV-associated myelopathy in a cohort of HTLV-I and HTLV-II-infected blood donors. The REDS investigatorsE L Murphy, J Fridey, J W Smith, et al.
Neurology|September 10, 2009
Neurologic abnormalities in HTLV-I- and HTLV-II-infected individuals without overt myelopathyH H Biswas, J W Engstrom, Z Kaidarova, et al.
Physical Review Letters|December 27, 2015
Towards a Mg Lattice Clock: Observation of the ^{1}S_{0}-^{3}P_{0} Transition and Determination of the Magic WavelengthA P Kulosa, D Fim, K H Zipfel, et al.
Expert Review of Gastroenterology & Hepatology|March 21, 2024
Histologic assessments in ulcerative colitis: the evidence behind a new endpoint in clinical trialsRish K Pai, Geert D'Haens, Taku Kobayashi, et al.
Digestive Diseases and Sciences|May 3, 2024
Patient and Health Care Professional Perceptions of the Experience and Impact of Symptoms of Moderate-to-Severe Crohn's Disease in US and Europe: Results from the Cross-Sectional CONFIDE StudyStefan Schreiber, Theresa Hunter Gibble, Remo Panaccione, et al.
Crohn'S & Colitis 360|May 14, 2025
US and European Patient and Health Care Professional Perspectives on Fatigue in Ulcerative Colitis and Crohn's Disease: Results From the Communicating Needs and Features of Inflammatory Bowel Disease Experiences SurveyRemo Panaccione, Alison Potts Bleakman, Stefan Schreiber, et al.
Diabetes, Obesity & Metabolism|February 4, 2026
A treat-to-target approach for obesity management: A post hoc analysis of the SURMOUNT-5 trialCarel W le Roux, Luca Busetto, Louis Aronne, et al.
Rheumatology and Therapy|December 19, 2025
Does HLA-B27 Status Influence Ixekizumab Efficacy in Axial Spondyloarthritis? Results From the COAST-V, COAST-W, and COAST-X TrialsJohn D Reveille, Martin Rudwaleit, Proton Rahman, et al.
Physical Review Letters|February 10, 2025
Lattice Light Shift Evaluations in a Dual-Ensemble Yb Optical Lattice ClockTobias Bothwell, Benjamin D Hunt, Jacob L Siegel, et al.
Crohn'S & Colitis 360|February 5, 2024
Association of Bowel Urgency With Quality-of-Life Measures in Patients With Moderately-to-Severely Active Ulcerative Colitis: Results From Phase 3 LUCENT-1 (Induction) and LUCENT-2 (Maintenance) StudiesMillie D Long, Stefan Schreiber, Toshifumi Hibi, et al.
Pageof 13